Loan & Debt5 Nov 2026, 10:31 pm
Jubilant Pharmova Allots ₹800 Cr NCDs
AI Summary
Jubilant Pharmova Limited has approved the allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating to ₹800 crore on a private placement basis. The NCDs have a face value of ₹1,00,000 each and will mature in 3 years with an interest rate of 8.50% per annum. The allotment was approved by the Finance Committee of the Company on November 5, 2026. This issuance is a significant debt financing activity for the company.
Key Highlights
- Allotment of 80,000 NCDs worth ₹800 crore approved.
- NCDs are unsecured, rated, listed, and redeemable.
- Tenure of the instrument is 3 years.
- Coupon rate offered is 8.50% per annum.
- Allotment made on a private placement basis.
Price Impact
More from JUBLPHARMA